Literature DB >> 15785159

Pheochromocytoma, thyroid disease, and hyperparathyroidism.

Emanuel L Bravo1.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15785159      PMCID: PMC8109564          DOI: 10.1111/j.1524-6175.2005.04109.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  8 in total

Review 1.  Thyroid hormone and blood pressure regulation.

Authors:  Sara Danzi; Irwin Klein
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

2.  Biochemical diagnosis of pheochromocytoma: which test is best?

Authors:  Jacques W M Lenders; Karel Pacak; McClellan M Walther; W Marston Linehan; Massimo Mannelli; Peter Friberg; Harry R Keiser; David S Goldstein; Graeme Eisenhofer
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

3.  Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery.

Authors:  G Bernini; A Moretti; S Lonzi; C Bendinelli; P Miccoli; A Salvetti
Journal:  Metabolism       Date:  1999-03       Impact factor: 8.694

4.  6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma.

Authors:  K Pacak; G Eisenhofer; J A Carrasquillo; C C Chen; S T Li; D S Goldstein
Journal:  Hypertension       Date:  2001-07       Impact factor: 10.190

Review 5.  Pheochromocytoma: an approach to antihypertensive management.

Authors:  Emmanuel L Bravo
Journal:  Ann N Y Acad Sci       Date:  2002-09       Impact factor: 5.691

Review 6.  Cardiovascular hemodynamics and exercise tolerance in thyroid disease.

Authors:  George J Kahaly; Christoph Kampmann; Susanne Mohr-Kahaly
Journal:  Thyroid       Date:  2002-06       Impact factor: 6.568

7.  A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines.

Authors:  Anna M Sawka; Roman Jaeschke; Ravinder J Singh; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

8.  Pheochromocytoma: state-of-the-art and future prospects.

Authors:  Emmanuel L Bravo; Rodrigo Tagle
Journal:  Endocr Rev       Date:  2003-08       Impact factor: 19.871

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.